295 related articles for article (PubMed ID: 16540354)
21. Severe iron overload with a novel aminolevulinate synthase mutation and hepatitis C infection. A case report.
Lee P; Rice L; McCarthy JJ; Beutler E
Blood Cells Mol Dis; 2009; 42(1):1-4. PubMed ID: 18823803
[TBL] [Abstract][Full Text] [Related]
22. A Japanese family with X-linked sideroblastic anemia affecting females and manifesting as macrocytic anemia.
Katsurada T; Kawabata H; Kawabata D; Kawahara M; Nakabo Y; Takaori-Kondo A; Yoshida Y
Int J Hematol; 2016 Jun; 103(6):713-7. PubMed ID: 26862056
[TBL] [Abstract][Full Text] [Related]
23. Different haematological picture of congenital sideroblastic anaemia in a hemizygote and a heterozygote.
Aguiar E; Freitas MI; Barbot J
Br J Haematol; 2014 Aug; 166(4):469. PubMed ID: 24862439
[No Abstract] [Full Text] [Related]
24. X-linked sideroblastic anemia due to ALAS2 intron 1 enhancer element GATA-binding site mutations.
Campagna DR; de Bie CI; Schmitz-Abe K; Sweeney M; Sendamarai AK; Schmidt PJ; Heeney MM; Yntema HG; Kannengiesser C; Grandchamp B; Niemeyer CM; Knoers NV; Swart S; Marron G; van Wijk R; Raymakers RA; May A; Markianos K; Bottomley SS; Swinkels DW; Fleming MD
Am J Hematol; 2014 Mar; 89(3):315-9. PubMed ID: 24166784
[TBL] [Abstract][Full Text] [Related]
25. A novel hemizygous I418S mutation in the ALAS2 gene in a young Korean man with X-linked sideroblastic anemia.
Moon SY; Jun IJ; Kim JE; Lee SJ; Kim HK; Yoon SS
Ann Lab Med; 2014 Mar; 34(2):159-62. PubMed ID: 24624355
[No Abstract] [Full Text] [Related]
26. Lethal ALAS2 mutation in males X-linked sideroblastic anaemia.
Rose C; Callebaut I; Pascal L; Oudin C; Fournier M; Gouya L; Lambilliotte A; Kannengiesser C
Br J Haematol; 2017 Aug; 178(4):648-651. PubMed ID: 27292130
[No Abstract] [Full Text] [Related]
27. [Genetics of hereditary iron overload].
Le Gall JY; Jouanolle AM; Fergelot P; Mosser J; David V
Bull Acad Natl Med; 2004; 188(2):247-62; discussion 262-3. PubMed ID: 15506716
[TBL] [Abstract][Full Text] [Related]
28. Hemochromatosis and severe iron overload associated with compound heterozygosity for TFR2 R455Q and two novel mutations TFR2 R396X and G792R.
Lee PL; Barton JC
Acta Haematol; 2006; 115(1-2):102-5. PubMed ID: 16424658
[TBL] [Abstract][Full Text] [Related]
29. X-linked sideroblastic anaemia due to ALAS₂ mutations in the Netherlands: a disease in disguise.
Donker AE; Raymakers RA; Nieuwenhuis HK; Coenen MJ; Janssen MC; MacKenzie MA; Brons PP; Swinkels DW
Neth J Med; 2014 May; 72(4):210-7. PubMed ID: 24829177
[TBL] [Abstract][Full Text] [Related]
30. [Iron overload and HFE gene].
Deugnier Y; Moirand R; Guyader D; Jouanolle AM; Brissot P
Gastroenterol Clin Biol; 1999 Jan; 23(1):122-31. PubMed ID: 10219613
[No Abstract] [Full Text] [Related]
31. Iron overload complicating sideroblastic anemia--is the gene for hemochromatosis responsible?
Barron R; Grace ND; Sherwood G; Powell LW
Gastroenterology; 1989 Apr; 96(4):1204-6. PubMed ID: 2925065
[TBL] [Abstract][Full Text] [Related]
32. A Novel g.55040074delT in ALAS2 Gene Resulting in a Monomeric Protein and Severe Sideroblastic Anemia Phenotype.
Bhatia P; Singh A; Hedge A
J Pediatr Hematol Oncol; 2017 Aug; 39(6):463-465. PubMed ID: 28731922
[TBL] [Abstract][Full Text] [Related]
33. [Hemochromatotic cirrhosis complicating pyridoxine-sensitive hereditary sideroblastic anemia. Case report].
Abadia R; Rochant H; Levy VG
Ann Med Interne (Paris); 1983; 134(4):327-32. PubMed ID: 6614712
[TBL] [Abstract][Full Text] [Related]
34. [A case report of X-linked sideroblastic anemia with novel ALAS2 gene mutation].
Bao SJ; Zhu HM; Tong Y; Hao D; Ling Y; Yuan W; Zhou Y; Sun ZQ
Zhonghua Xue Ye Xue Za Zhi; 2019 Aug; 40(8):684. PubMed ID: 31495138
[No Abstract] [Full Text] [Related]
35. Recent advances in the understanding of inherited sideroblastic anaemia.
Camaschella C
Br J Haematol; 2008 Oct; 143(1):27-38. PubMed ID: 18637800
[TBL] [Abstract][Full Text] [Related]
36. Late-onset X-linked sideroblastic anemia. Missense mutations in the erythroid delta-aminolevulinate synthase (ALAS2) gene in two pyridoxine-responsive patients initially diagnosed with acquired refractory anemia and ringed sideroblasts.
Cotter PD; May A; Fitzsimons EJ; Houston T; Woodcock BE; al-Sabah AI; Wong L; Bishop DF
J Clin Invest; 1995 Oct; 96(4):2090-6. PubMed ID: 7560104
[TBL] [Abstract][Full Text] [Related]
37. Gene symbol: ALAS2. Disease: sideroblastic anaemia.
Gonçalves P; Pereira JC; Ribeiro ML
Hum Genet; 2004 Nov; 115(6):532. PubMed ID: 15678585
[No Abstract] [Full Text] [Related]
38. Sideroblastic anemia, iron overload, and ALAS2 R452S in African-American males: phenotype and genotype features of five unrelated patients.
Lee PL; Reid TJ; Bottomley SS; Barton JC
Am J Hematol; 2011 Sep; 86(9):787-9. PubMed ID: 21800356
[No Abstract] [Full Text] [Related]
39. Novel human pathological mutations. Gene symbol: ALAS2. Disease: sideroblastic anaemia.
Pereira JC; Barbot J; Ribeiro ML
Hum Genet; 2009 Aug; 126(2):333. PubMed ID: 19693999
[No Abstract] [Full Text] [Related]
40. Novel mutations in the ALAS2 gene from patients with X-linked sideroblastic anemia.
Li J; Chen L; Lin Y; Ru K
Int J Lab Hematol; 2020 Aug; 42(4):e160-e163. PubMed ID: 32297424
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
